Prediction of therapeutic response and cancer outcomes in solid tumours via in silico clinical trials
Asghar, Uzma Saddia, Griffiths, Matthew, Kubeyev, Amanzhol, Laurie, Jordan, Giorni, Andrea, Zillmann da Silva, Luiz A, Sivasubramaniam, Prabu, Foster, Matthew, Biankin, Andrew V.
Published in Journal of clinical oncology (01.06.2024)
Published in Journal of clinical oncology (01.06.2024)
Get full text
Journal Article
A phase I trial of selective PI3K inhibitor taselisib (tas) plus palbociclib (palb) with and without endocrine therapy incorporating pharmacodynamic (PD) studies in patients (pts) with advanced cancers
Lim, Joline Si Jing, Asghar, Uzma Saddia, Diamantis, Nikolaos, Ward, Sarah Emily, Parmar, Mona, Purchase, Beth, Raynaud, Florence I., Swales, Karen E, Hrebien, Sarah, Hall, Emma, Tovey, Holly, Bye, Hannah, Proszek, Paula, Lopez, Juanita Suzanne, Turner, Alison Joanne, De Bono, Johann S., Banerji, Udai, Yap, Timothy Anthony, Turner, Nicholas C.
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Phase 1/2 study of oral rucaparib: Final phase 1 results
Kristeleit, Rebecca Sophie, Burris, Howard A., LoRusso, Patricia, Patel, Manish R., Asghar, Uzma Saddia, El-Khouly, Fatima, Calvert, Alan Hilary, Infante, Jeffrey R., Hilton, John Frederick, Tolaney, Sara M., Kittaneh, Muaiad, Giordano, Heidi, Borrow, Jennifer, Jaw-Tsai, Sarah S., Shapiro, Geoffrey
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article